carbidopa 23.75 MG / levodopa 95 MG [Rytary]

RxNorm Status History#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
	23.75 MG / 1 EACH	carbidopa
	95 MG / 1 EACH	levodopa

Ingredient, RxCUI table
Ingredient	RxCUI
carbidopa	2019
levodopa	6375

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	carbidopa 23.75 MG / levodopa 95 MG [Rytary]	1	NAMES
RxNorm Name	carbidopa 23.75 MG / levodopa 95 MG [Rytary]	1	NAMES
TTY	SBDC	1	ATTRIBUTES
RxCUI	1599264	1	CODES

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	N04BA	Dopa and dopa derivatives	ATC1-4		levodopa
FDASPL	D024322	Amino Acids, Aromatic	CHEM	has_chemical_structure	levodopa
FDASPL	N0000193220	Aromatic Amino Acid	EPC	has_epc	levodopa
FDASPL	N0000175754	Aromatic Amino Acid Decarboxylation Inhibitor	EPC	has_epc	carbidopa
FDASPL	N0000175755	DOPA Decarboxylase Inhibitors	MOA	has_moa	carbidopa
MEDRT	D002230	Carbidopa	CHEM	has_ingredient	carbidopa
MEDRT	D007980	Levodopa	CHEM	has_ingredient	levodopa
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	levodopa
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	carbidopa
MEDRT	D015812	Glaucoma, Angle-Closure	DISEASE	ci_with	carbidopa
MEDRT	D015812	Glaucoma, Angle-Closure	DISEASE	ci_with	levodopa
MEDRT	D008545	Melanoma	DISEASE	ci_with	levodopa
MEDRT	D008545	Melanoma	DISEASE	ci_with	carbidopa
MEDRT	D010300	Parkinson Disease	DISEASE	may_treat	levodopa
MEDRT	D010300	Parkinson Disease	DISEASE	may_treat	carbidopa
MEDRT	N0000000203	Dopamine Receptor Interactions	MOA	has_moa	carbidopa
MEDRT	N0000000203	Dopamine Receptor Interactions	MOA	has_moa	levodopa
MEDRT	N0000000133	Enzyme Inhibitors	MOA	has_moa	carbidopa
MEDRT	N0000000184	Monoamine Oxidase Inhibitors	MOA	ci_moa	carbidopa
MEDRT	N0000000184	Monoamine Oxidase Inhibitors	MOA	ci_moa	levodopa
MEDRT	N0000009183	Increased Central Nervous System Dopamine Activity	PE	has_pe	carbidopa
MEDRT	N0000009183	Increased Central Nervous System Dopamine Activity	PE	has_pe	levodopa

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Rytary	rxnav_allrelated
DF	DF	Extended Release Oral Capsule	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	carbidopa	rxnav_allrelated
IN	IN	levodopa	rxnav_allrelated
MIN	MIN	carbidopa / levodopa	rxnav_allrelated
SBD	SBD	8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule [Rytary]	rxnav_allrelated
SBDC	SBDC	carbidopa 23.75 MG / levodopa 95 MG [Rytary]	rxnav_allrelated
SBDF	SBDF	carbidopa / levodopa Extended Release Oral Capsule [Rytary]	rxnav_allrelated
SBDG	SBDG	Rytary Oral Product	rxnav_allrelated
SBDG	SBDG	Rytary Pill	rxnav_allrelated
SCD	SCD	8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule	rxnav_allrelated
SCDC	SCDC	carbidopa 23.75 MG	rxnav_allrelated
SCDC	SCDC	levodopa 95 MG	rxnav_allrelated
SCDF	SCDF	carbidopa / levodopa Extended Release Oral Capsule	rxnav_allrelated
SCDG	SCDG	carbidopa / levodopa Oral Product	rxnav_allrelated
SCDG	SCDG	carbidopa / levodopa Pill	rxnav_allrelated

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	RXNAV_HUMAN_DRUG	US